Results 191 to 200 of about 209,630 (306)
Phenotypic and molecular characterisation of CDK13-related congenital heart defects, dysmorphic facial features and intellectual developmental disorders [PDF]
Andrews, Marisa V +2 more
core +2 more sources
ABSTRACT Transcatheter aortic valve implantation (TAVI) has become an established treatment for severe aortic stenosis. However, the need for unplanned conversion to cardiac surgery (CS) during TAVI remains an infrequent but critical event. It is unclear whether this risk is higher in patients undergoing urgent procedures.
Nikolaos Ktenopoulos +12 more
wiley +1 more source
Small patients - Big needs: A material-based approach to develop miniaturised valves for congenital heart diseases. [PDF]
Sonntag S +7 more
europepmc +1 more source
Surgical treatment for tricuspid valve regurgitation combining with acquired valvular heart disease.
Nobuyuki Fujii
openalex +2 more sources
ABSTRACT Alcohol septal ablation is a well‐established treatment method for patients with hypertrophic cardiomyopathy. We present a case report of a patient with transposition of the great arteries (TGA) after a Mustard procedure, who developed significant right ventricular outflow tract obstruction (RVOTO), functionally resembling subaortic stenosis ...
Vera Osberghaus +6 more
wiley +1 more source
Microbiota in Gut, Oral Cavity, and Mitral Valves Are Associated With Rheumatic Heart Disease
Xuerui Shi +11 more
openalex +1 more source
ABSTRACT Background Frailty is associated with poorer short‐term outcomes after transcatheter aortic valve implantation (TAVI), and national guidelines recommend an assessment of frailty as part of the decision‐making process. However, multiple frailty indices are currently used in clinical practice, and it is unclear which has the best discrimination ...
Timothy J. Bagnall +11 more
wiley +1 more source
Treatment of Severe Tricuspid Regurgitation with the TricValve System Implantation-Preliminary Results of a Prospective Registry. [PDF]
Rdzanek A +9 more
europepmc +1 more source
Real‐World Edoxaban Concentrations in Older Patients Receiving Reduced‐Dose Regimens
Real‐world edoxaban concentrations in older patients receiving reduced‐dose regimens. Low trough concentrations (< 12 ng/mL) were associated with an increased risk of thromboembolism. Among patients meeting the ELDERCARE‐AF criteria, low drug levels were more frequent with the 15 mg regimen than with the 30 mg regimen.
Sung‐Chun Tang +8 more
wiley +1 more source

